CERENO SCIENTIFIC AB B (4A1) — Financial Flexibility Index
Latest as of December 2025:
-0.19x
CERENO SCIENTIFIC AB B (4A1) has a Financial Flexibility Index of -0.19x as of December 2025. Free cash flow of €-28.31 Million (operating CF €-38.03 Million minus capex €9.72 Million) represents 0% of total liabilities (€150.20 Million).
Financial Flexibility Index
-0.19x
Free Cash Flow / Total Liabilities
Free Cash Flow
€-28.31 Million
Operating CF − Capex
Total Liabilities
€150.20 Million
EUR
Capital Expenditures
€9.72 Million
EUR
CERENO SCIENTIFIC AB B Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for CERENO SCIENTIFIC AB B across 5 annual periods. See CERENO SCIENTIFIC AB B (4A1) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for CERENO SCIENTIFIC AB B (2021–2025)
Year-by-year free cash flow to debt coverage for CERENO SCIENTIFIC AB B. For the full company profile including market capitalisation, see 4A1 company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.45x | €-67.52 Million | €-111.86 Million | €150.20 Million | ▼ -434.8% |
| 2024 | -0.08x | €-18.65 Million | €-103.42 Million | €221.85 Million | ▼ -146.6% |
| 2023 | 0.18x | €12.36 Million | €-36.92 Million | €68.56 Million | ▼ -93.4% |
| 2022 | 2.75x | €38.92 Million | €-18.62 Million | €14.14 Million | ▼ -7.2% |
| 2021 | 2.97x | €31.67 Million | €-13.14 Million | €10.67 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities